Related Experiment Video
Updated: Aug 8, 2026
07:10
Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Current pharmacotherapeutic recommendations for acute pancreatitis
1Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium. jan.dewaele@UGent.be
Expert Opinion on Pharmacotherapy
|May 26, 2006
Summary
Acute pancreatitis severity ranges widely, with severe cases leading to complications and mortality. Current treatments lack efficacy, and prophylactic antibiotics show no benefit, necessitating better patient stratification for trials.
Area of Science:
- Gastroenterology and Hepatology
- Critical Care Medicine
- Infectious Diseases
Background:
- Acute pancreatitis presents a spectrum of severity, from mild to life-threatening.
- Severe acute pancreatitis is associated with significant local and systemic complications, including infectious complications and pancreatic necrosis.
- Pancreatic necrosis is a major determinant of mortality in severe acute pancreatitis.
Purpose of the Study:
- To review the current understanding of acute pancreatitis severity and complications.
- To evaluate the efficacy of existing therapeutic strategies and prophylactic antibiotic use.
- To highlight the need for improved risk stratification in clinical trials.
Main Methods:
- Review of existing literature on acute pancreatitis pathogenesis, complications, and treatment strategies.
- Analysis of the role of infectious complications and pancreatic necrosis.
- Discussion of the evidence regarding prophylactic antibiotic administration.
Main Results:
- No current strategies have proven effective in preventing organ dysfunction progression.
- Prophylactic antibiotic use in acute pancreatitis has been questioned due to lack of demonstrated benefit in recent studies.
- Identifying patients at high risk for complications is crucial for effective clinical trial design.
Conclusions:
- Effective treatments for severe acute pancreatitis and its complications remain elusive.
- The routine use of prophylactic antibiotics is not supported by current evidence.
- Improved risk stratification methods are essential for advancing research and improving patient outcomes in acute pancreatitis.
Related Concept Videos
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:25Acute Pancreatitis I: Introduction
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
01:27Acute Pancreatitis I: Introduction
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...